mutations and sophisticated kar yotype. It follows a linear evolution from the CLL clone with the recurrent acquisition of CDKN2AGenetic susceptibility mechanisms. Most susceptibility loci map to non-coding areas on the genome, are primarily situated in active promoters or enhancers, and modify the binding sites of numerous transcription elements.D